RCM

RA Capital Management Portfolio holdings

AUM $5.94B
1-Year Est. Return 18.15%
This Quarter Est. Return
1 Year Est. Return
+18.15%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$7.22B
AUM Growth
+$986M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
109
New
Increased
Reduced
Closed

Top Buys

1
+$236M
2
+$226M
3
+$206M
4
ICVX
Icosavax, Inc. Common Stock
ICVX
+$171M
5
DICE
DICE Therapeutics, Inc. Common Stock
DICE
+$171M

Top Sells

1
+$112M
2
+$95.8M
3
+$57.6M
4
CERE
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
+$56.4M
5
CCXI
ChemoCentryx, Inc.
CCXI
+$56.1M

Sector Composition

1 Healthcare 99.06%
2 Financials 0.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$1.18B 16.32%
7,387,900
+581,559
2
$435M 6.03%
2,097,794
-462,124
3
$236M 3.28%
+13,150,849
4
$226M 3.13%
+5,340,130
5
$209M 2.9%
9,011,651
6
$206M 2.85%
+9,607,028
7
$190M 2.64%
5,427,655
+59,204
8
$188M 2.6%
8,670,644
9
$174M 2.42%
11,120,973
10
$173M 2.4%
236,114
11
$171M 2.37%
+5,779,347
12
$171M 2.36%
+5,208,911
13
$169M 2.35%
6,991,003
14
$156M 2.16%
5,605,129
15
$145M 2.01%
+9,770,773
16
$136M 1.89%
4,098,332
+755,589
17
$136M 1.89%
5,614,428
18
$127M 1.76%
+7,236,454
19
$124M 1.72%
5,943,594
20
$119M 1.65%
4,417,259
21
$118M 1.63%
4,965,588
22
$104M 1.45%
18,417,458
23
$100M 1.39%
3,115,008
24
$98.9M 1.37%
3,896,865
+31,057
25
$97.3M 1.35%
4,965,769
1
2 3 4 5